Premium
Serotonergic polymorphisms and psychotic disorders in populations from North Spain
Author(s) -
Mata I.,
Arranz M.J.,
Patiño A.,
Lai T.,
Beperet M.,
Sierrasesumaga L.,
Clark D.,
PerezNievas F.,
Richards L.,
Ortuño F.,
Sham P.,
Kerwin R.W.
Publication year - 2003
Publication title -
american journal of medical genetics part b: neuropsychiatric genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.393
H-Index - 126
eISSN - 1552-485X
pISSN - 1552-4841
DOI - 10.1002/ajmg.b.20150
Subject(s) - serotonergic , serotonin transporter , psychosis , genetics , biology , gene , genetic association , intron , serotonin , genotype , receptor , medicine , psychiatry , single nucleotide polymorphism
There is strong biological evidence relating alterations in the serotonergic system with mental disorders. These alterations may be originated at the DNA level by sequence mutations that alter the functioning of serotonin receptors and transporter. To test this hypothesis we investigated three genetic variants of the 5‐HT2A receptor (−1438G/A, 102T/C and His452Tyr) and two variants of the serotonin transporter (a VNTR in the second intron and a 44 bp insertion/delition in the promoter region of the gene) in a clinical sample recruited in a human isolate and in surrounding areas in Northern Spain (N = 257) and in ethnically matched controls (N = 334). No clear association was found between 5‐HT2A variants and psychosis. However, marginal associations were observed between the 5‐HTT LPR and VNTR variants and psychosis ( P ≤ 0.05) indicating a minor contribution to psychosis of genetic alterations in this gene. © 2003 Wiley‐Liss, Inc.